Last reviewed · How we verify
DTP-HepB-Hib vaccine & IPV — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
DTP-HepB-Hib vaccine & IPV (DTP-HepB-Hib vaccine & IPV) — LG Chem.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| DTP-HepB-Hib vaccine & IPV TARGET | DTP-HepB-Hib vaccine & IPV | LG Chem | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- DTP-HepB-Hib vaccine & IPV CI watch — RSS
- DTP-HepB-Hib vaccine & IPV CI watch — Atom
- DTP-HepB-Hib vaccine & IPV CI watch — JSON
- DTP-HepB-Hib vaccine & IPV alone — RSS
Cite this brief
Drug Landscape (2026). DTP-HepB-Hib vaccine & IPV — Competitive Intelligence Brief. https://druglandscape.com/ci/dtp-hepb-hib-vaccine-ipv. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab